samuel rabkin

Professor

Massachusetts General Hospital and Harvard Medical School

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Hiroaki Wakimoto

Associate professor

Massachusetts General Hospital

UNITED STATES

View details

Dipongkor Saha

California Northstate University College of Pharmacy

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

samuel rabkin

Research Interests

Explore related searches

Contact this professor

Articles (14)

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

Safety of non-replicative and oncolytic replication-selective HSV vectors

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells

Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy

An armed oncolytic virus for GBM destruction

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV

The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?

Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic Virotherapy

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

Collaborators (2)

Hiroaki Wakimoto

Dipongkor Saha

Make your next move.